United States · Health Care · USD (Thousands) · Annual
Reported figures and Equlion model projections for the next 5 years.
Sector average
Sector average (own scale)
Amounts in USD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for MUSTANG BIO, INC.? It covers the balance sheet, income statement, cash flow and Equlion model projections.
| Key metrics | Actual | Forecast | ||||
|---|---|---|---|---|---|---|
| Metric | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
| ROE | -67.93% | -173.24% | 236.81% | 70.36% | 41.4% | 29.55% |
|---|---|---|---|---|---|---|
| Sector average | 20.42% | 71.17% | 5.82% | 58.79% | 17.46% | 2.74% |
| ROA | -14.28% | -66.82% | -98.97% | -99.08% | -99.38% | -100.47% |
| Total Assets | $17,593.00K | $8,881.77K | $8,881.77K | $8,881.77K | $8,881.77K | $8,881.77K |
| Sector average | $3,280,499.23K | $3,298,345.31K | $3,676,894.01K | |||
| Net Income | -$1,921.00K | -$8,845.85K | -$8,789.92K | -$8,799.97K | -$8,826.33K | -$8,923.90K |
| $4,262,561.28K |
| $4,994,412.92K |
| $5,761,557.24K |